Luis
Montuenga Badía
Catedrático de Universidad
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (7)
2018
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
2017
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
2016
-
A novel epigenetic signature for early diagnosis in lung cancer
Clinical Cancer Research, Vol. 22, Núm. 13, pp. 3361-3371
-
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
Oncotarget, Vol. 7, Núm. 16, pp. 22752-22769
2014
-
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
EMBO Molecular Medicine, Vol. 6, Núm. 4, pp. 539-550
2008
-
A microRNA DNA methylation signature for human cancer metastasis
Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Núm. 36, pp. 13556-13561